Global

‡ In these countries please contact our distributor

VERSAJET Clinical Efficacy

Precision and Performance

 

Clinical Efficacy
Helps reduce time to wound closure 1,2
Creates a smooth wound bed for improved graft and synthetic dressing results 4
Reduces bacterial burden, soft tissue biofilms and other inhibitory elements 1-3
Removes unwanted tissue and contaminants, while preserving healthy tissue 1,3,5
Accesses difficult-to-reach and contoured areas with ease and control 5

Reduced wound closure time by 33% 8

 

Sharp debridement
(n=12)
Reduced wound closure time by 33%

VERSAJET system

(n=12)

 

 

Healing time (days)

 

 

One operative procedure required in 76% of patients 2

One operative procedure required in 76% of patients

 

 

 

 

Reduced bacterial burden 2

Before VERSAJET

Reduced bacterial burden

After VERSAJET

 

 

 

CFU / cm 2

 

 

 

Immediate coverage successful in 95% of graft procedures 4

Immediate coverage successful in 95% of graft procedures

*Seen in patients with venous insufficiency left uncontrolled in the post-operative period.